Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Bader, Michael Prof. Dr. (18) Bähring, Sylvia Dr. (6) Birchmeier, Walter Prof. Dr. (15) Birchmeier-Kohler, Carmen Prof. Dr. (10) Blankenstein, Thomas Prof. Dr. (11) Falcke, Martin Prof. Dr. (3) Fielitz, Jens Dr. (1) Gerhardt, Holger Prof. Dr. (4) Gotthardt, Michael Prof. Dr. (2) Hammes-Lewin, Annette Dr. (1) Höpken, Uta Elisabeth PD Dr. (2) Hübner, Norbert Prof. Dr. (1) Ivics, Zoltan Dr. (6) Izsvak, Zsuzsanna Dr. (6) Jentsch, Thomas Prof. Dr. (18) Kammertöns, Thomas Dr. (2) Kettenmann, Helmut Prof. Dr. (15) Kettritz, Ralph Prof. Dr. (5) Klußmann, Enno PD Dr. (1) Koch, Gudrun (2) Kowenz-Leutz, Elisabeth Dr. (1) Kühn, Ralf Dr. (4) Landthaler, Markus Prof. Dr. (1) Lee, Young-Ae Prof. Dr. (1) Leutz, Achim Prof. Dr. (5) Lewin, Gary Prof. Dr. (13) Luft, Friedrich Prof. Dr. (121) Mathas, Stephan Dr. (1) Meyer, Irmtraud Margret Prof. Dr. (1) Morano, Ingo Prof. Dr. (15) Müller, Dominik Prof. Dr. (6) Niendorf, Thoralf Prof. Dr. (3) Nolte, Christiane Dr. (1) Ohler, Uwe Prof. Dr. (2) Perrot, Andreas (1) Pezzutto, Antonio Prof. Dr. (3) Potente, Michael Prof. Dr. (1) Rahn, Hans-Peter Dr. (2) Rajewsky, Klaus Prof. Dr. (1) Rajewsky, Nikolaus Prof. Dr. (4) Rathjen, Fritz Prof. Dr. (1) Rocks, Oliver Dr. (1) Sander, Maike Prof. Dr. (1) Schlag, Peter M. Prof. Dr. (13) Schulz-Menger, Jeanette Prof. Dr. (3) Selbach, Matthias Prof. Dr. (2) Sommer, Thomas Prof. Dr. (1) Sporbert, Anje Dr. (1) Spuler, Simone Prof. (4) Stein, Ulrike Prof. Dr. (9) Wallukat, Gerd Dr. (1) Walther, Wolfgang Prof. Dr. (9) Wanker, Erich Prof. Dr. (14) Willimsky, Gerald Dr. (1) Willnow, Thomas Prof. Dr. (10) (-) Dechend, Ralf Priv. Doz. (3) (-) Scheidereit, Claus Prof. Dr. (10) AG Müller/Dechend (ECRC) (1) Biologie maligner Lymphome (1) Hypertonie-vermittelter Endorganschaden (1) Hypertonie bedingte Endorganschäden (1) 1992 (3) 1993 (3) 1994 (5) 1995 (2) 1996 (7) 1997 (8) (-) 1998 (4) (-) 1999 (7) 2000 (12) 2001 (13) 2002 (16) 2003 (13) 2004 (14) 2005 (15) 2006 (9) 2007 (17) 2008 (18) 2009 (17) 2010 (10) 2011 (15) 2012 (18) 2013 (19) 2014 (22) 2015 (20) 2016 (23) 2017 (19) 2018 (14) 2019 (19) 2020 (26) 2021 (17) 2022 (15) 2023 (16) 2024 (3) 11 Ergebnisse: Active Filter: Dechend, Ralf Priv. Doz.Scheidereit, Claus Prof. Dr.19981999 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 28. September 1999 / Circulation Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-kappaB and induces tissue factor and PAI-1 expression - A potential link to accelerated arteriosclerosis R. Dechend M. Maass J. Gieffers R. Dietz C. Scheidereit A. Leutz D.C. Gulba 01. April 1999 / Mol Cell Biol NF-kappaB function in growth control: Regulation of cyclin D1 expression and G(0)G(1)-to-S-Phase transition M. Hinz D. Krappmann A. Eichten A. Heder C. Scheidereit M. Strauss 01. September 1999 / EMBO J NF-kappaB p105 is a target of I kappaB kinases and controls signal induction of Bcl-3-p50 complexes V. Heissmeyer D. Krappmann F.G. Wulczyn C. Scheidereit 01. April 1998 / Nucleic Acids Res Signal-dependent degradation of IkappaBalpha is mediated by an inducible destruction box that can be transferred to NF-kappaB, bcl-3 or p53 F.G. Wulczyn D. Krappmann C. Scheidereit 01. Mai 1998 / Mol Cell Biol Alternative splicing variants of IkappaBbeta establish differential NF-kappaB signal responsiveness in human cells F. Hirano M.R. Chung H. Tanaka N. Maruyama I. Makino D.D. Moore C. Scheidereit 17. September 1998 / Nature Signal transduction. Docking IkappaB kinases C. Scheidereit 01. Januar 1999 / Hypertension Hypertension-induced end-organ damage - A new transgenic approach to an old problem F.C. Luft E. Mervaala D.N. Mueller V. Gross F. Schmidt J.K. Park C. Schmitz A. Lippoldt V. Breu R. Dechend D. Dragun W. Schneider D. Ganten H. Haller 28. Januar 1999 / Oncogene Molecular mechanisms of constitutive NF-kappaB/Rel activation in Hodgkin/Reed-Sternberg cells D. Krappmann F. Emmerich U. Kordes E. Scharschmidt B. Doerken C. Scheidereit 03. Juni 1999 / Oncogene The Bcl-3 oncoprotein acts as a bridging factor between NF-kappa B/Rel and nuclear co-regulators R. Dechend F. Hirano K. Lehmann V. Heissmeyer S. Ansieau F.G. Wulczyn C. Scheidereit A. Leutz 01. März 1998 / Mol Cell Biol Functional interference of Sp1 and NF-kappaB through the same DNA binding site F. Hirano H. Tanaka Y. Hirano M. Hiramoto H. Handa I. Makino C. Scheidereit Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
28. September 1999 / Circulation Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-kappaB and induces tissue factor and PAI-1 expression - A potential link to accelerated arteriosclerosis R. Dechend M. Maass J. Gieffers R. Dietz C. Scheidereit A. Leutz D.C. Gulba
01. April 1999 / Mol Cell Biol NF-kappaB function in growth control: Regulation of cyclin D1 expression and G(0)G(1)-to-S-Phase transition M. Hinz D. Krappmann A. Eichten A. Heder C. Scheidereit M. Strauss
01. September 1999 / EMBO J NF-kappaB p105 is a target of I kappaB kinases and controls signal induction of Bcl-3-p50 complexes V. Heissmeyer D. Krappmann F.G. Wulczyn C. Scheidereit
01. April 1998 / Nucleic Acids Res Signal-dependent degradation of IkappaBalpha is mediated by an inducible destruction box that can be transferred to NF-kappaB, bcl-3 or p53 F.G. Wulczyn D. Krappmann C. Scheidereit
01. Mai 1998 / Mol Cell Biol Alternative splicing variants of IkappaBbeta establish differential NF-kappaB signal responsiveness in human cells F. Hirano M.R. Chung H. Tanaka N. Maruyama I. Makino D.D. Moore C. Scheidereit
01. Januar 1999 / Hypertension Hypertension-induced end-organ damage - A new transgenic approach to an old problem F.C. Luft E. Mervaala D.N. Mueller V. Gross F. Schmidt J.K. Park C. Schmitz A. Lippoldt V. Breu R. Dechend D. Dragun W. Schneider D. Ganten H. Haller
28. Januar 1999 / Oncogene Molecular mechanisms of constitutive NF-kappaB/Rel activation in Hodgkin/Reed-Sternberg cells D. Krappmann F. Emmerich U. Kordes E. Scharschmidt B. Doerken C. Scheidereit
03. Juni 1999 / Oncogene The Bcl-3 oncoprotein acts as a bridging factor between NF-kappa B/Rel and nuclear co-regulators R. Dechend F. Hirano K. Lehmann V. Heissmeyer S. Ansieau F.G. Wulczyn C. Scheidereit A. Leutz
01. März 1998 / Mol Cell Biol Functional interference of Sp1 and NF-kappaB through the same DNA binding site F. Hirano H. Tanaka Y. Hirano M. Hiramoto H. Handa I. Makino C. Scheidereit